Loading…

Direct Reprogramming of Human Dermal Fibroblasts Into Endothelial Cells Using ER71/ETV2

Direct conversion or reprogramming of human postnatal cells into endothelial cells (ECs), bypassing stem or progenitor cell status, is crucial for regenerative medicine, cell therapy, and pathophysiological investigation but has remained largely unexplored. We sought to directly reprogram human post...

Full description

Saved in:
Bibliographic Details
Published in:Circulation research 2017-03, Vol.120 (5), p.848-861
Main Authors: Lee, Sangho, Park, Changwon, Han, Ji Woong, Kim, Ju Young, Cho, Kyuwon, Kim, Eun Jae, Kim, Sangsung, Lee, Shin-Jeong, Oh, Se Yeong, Tanaka, Yoshiaki, Park, In-Hyun, An, Hyo Jae, Shin, Claire Min, Sharma, Shraya, Yoon, Young-Sup
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c439t-93f2378b7b85c6ec71945aa34919857cedc923a964f804da3b1e5d4e54793f033
cites cdi_FETCH-LOGICAL-c439t-93f2378b7b85c6ec71945aa34919857cedc923a964f804da3b1e5d4e54793f033
container_end_page 861
container_issue 5
container_start_page 848
container_title Circulation research
container_volume 120
creator Lee, Sangho
Park, Changwon
Han, Ji Woong
Kim, Ju Young
Cho, Kyuwon
Kim, Eun Jae
Kim, Sangsung
Lee, Shin-Jeong
Oh, Se Yeong
Tanaka, Yoshiaki
Park, In-Hyun
An, Hyo Jae
Shin, Claire Min
Sharma, Shraya
Yoon, Young-Sup
description Direct conversion or reprogramming of human postnatal cells into endothelial cells (ECs), bypassing stem or progenitor cell status, is crucial for regenerative medicine, cell therapy, and pathophysiological investigation but has remained largely unexplored. We sought to directly reprogram human postnatal dermal fibroblasts to ECs with vasculogenic and endothelial transcription factors and determine their vascularizing and therapeutic potential. We utilized various combinations of 7 EC transcription factors to transduce human postnatal dermal fibroblasts and found that ER71/ETV2 (ETS variant 2) alone best induced endothelial features. KDR (kinase insert domain receptor) cells sorted at day 7 from ER71/ETV2-transduced human postnatal dermal fibroblasts showed less mature but enriched endothelial characteristics and thus were referred to as early reprogrammed ECs (rECs), and did not undergo maturation by further culture. After a period of several weeks' transgene-free culture followed by transient reinduction of ER71/ETV2, early rECs matured during 3 months of culture and showed reduced ETV2 expression, reaching a mature phenotype similar to postnatal human ECs. These were termed late rECs. While early rECs exhibited an immature phenotype, their implantation into ischemic hindlimbs induced enhanced recovery from ischemia. These 2 rECs showed clear capacity for contributing to new vessel formation through direct vascular incorporation in vivo. Paracrine or proangiogenic effects of implanted early rECs played a significant role in repairing hindlimb ischemia. This study for the first time demonstrates that ER71/ETV2 alone can directly reprogram human postnatal cells to functional, mature ECs after an intervening transgene-free period. These rECs could be valuable for cell therapy, personalized disease investigation, and exploration of the reprogramming process.
doi_str_mv 10.1161/CIRCRESAHA.116.309833
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5336520</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2006888077</sourcerecordid><originalsourceid>FETCH-LOGICAL-c439t-93f2378b7b85c6ec71945aa34919857cedc923a964f804da3b1e5d4e54793f033</originalsourceid><addsrcrecordid>eNpdkUFr3DAQhUVpabZpf0KLoZdenIw0kiVdCovjdBcCgU3SHoXslTcOtrWV7EL_fbVsmiY9DcN87zGPR8hHCmeUFvS8XG_KTXWzXC0P-xmCVoivyIIKxnMuJH1NFgCgc4kIJ-RdjA8AlCPTb8kJUwDIqF6QHxddcM2Ubdw--F2ww9CNu8y32Woe7JhduDDYPrvs6uDr3sYpZutx8lk1bv107_ouHUvX9zG7iwdhtZH0vLr9zt6TN63to_vwOE_J3WV1W67yq-tv63J5lTcc9ZRrbBlKVctaiaZwjaSaC2uRa6qVkI3bNpqh1QVvFfCtxZo6seVOcJmkgHhKvh5993M9JNqNU7C92YdusOG38bYzLy9jd292_pcRiIVgkAy-PBoE_3N2cTJDF5sUyY7Oz9FQJWihJWUqoZ__Qx_8HMYUzzCAQikFUiZKHKkm-BiDa5-eoWAO1Zl_1R12c6wu6T49T_Kk-tsV_gG_0pRF</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2006888077</pqid></control><display><type>article</type><title>Direct Reprogramming of Human Dermal Fibroblasts Into Endothelial Cells Using ER71/ETV2</title><source>Freely Accessible Journals</source><creator>Lee, Sangho ; Park, Changwon ; Han, Ji Woong ; Kim, Ju Young ; Cho, Kyuwon ; Kim, Eun Jae ; Kim, Sangsung ; Lee, Shin-Jeong ; Oh, Se Yeong ; Tanaka, Yoshiaki ; Park, In-Hyun ; An, Hyo Jae ; Shin, Claire Min ; Sharma, Shraya ; Yoon, Young-Sup</creator><creatorcontrib>Lee, Sangho ; Park, Changwon ; Han, Ji Woong ; Kim, Ju Young ; Cho, Kyuwon ; Kim, Eun Jae ; Kim, Sangsung ; Lee, Shin-Jeong ; Oh, Se Yeong ; Tanaka, Yoshiaki ; Park, In-Hyun ; An, Hyo Jae ; Shin, Claire Min ; Sharma, Shraya ; Yoon, Young-Sup</creatorcontrib><description>Direct conversion or reprogramming of human postnatal cells into endothelial cells (ECs), bypassing stem or progenitor cell status, is crucial for regenerative medicine, cell therapy, and pathophysiological investigation but has remained largely unexplored. We sought to directly reprogram human postnatal dermal fibroblasts to ECs with vasculogenic and endothelial transcription factors and determine their vascularizing and therapeutic potential. We utilized various combinations of 7 EC transcription factors to transduce human postnatal dermal fibroblasts and found that ER71/ETV2 (ETS variant 2) alone best induced endothelial features. KDR (kinase insert domain receptor) cells sorted at day 7 from ER71/ETV2-transduced human postnatal dermal fibroblasts showed less mature but enriched endothelial characteristics and thus were referred to as early reprogrammed ECs (rECs), and did not undergo maturation by further culture. After a period of several weeks' transgene-free culture followed by transient reinduction of ER71/ETV2, early rECs matured during 3 months of culture and showed reduced ETV2 expression, reaching a mature phenotype similar to postnatal human ECs. These were termed late rECs. While early rECs exhibited an immature phenotype, their implantation into ischemic hindlimbs induced enhanced recovery from ischemia. These 2 rECs showed clear capacity for contributing to new vessel formation through direct vascular incorporation in vivo. Paracrine or proangiogenic effects of implanted early rECs played a significant role in repairing hindlimb ischemia. This study for the first time demonstrates that ER71/ETV2 alone can directly reprogram human postnatal cells to functional, mature ECs after an intervening transgene-free period. These rECs could be valuable for cell therapy, personalized disease investigation, and exploration of the reprogramming process.</description><identifier>ISSN: 0009-7330</identifier><identifier>EISSN: 1524-4571</identifier><identifier>DOI: 10.1161/CIRCRESAHA.116.309833</identifier><identifier>PMID: 28003219</identifier><language>eng</language><publisher>United States: Lippincott Williams &amp; Wilkins Ovid Technologies</publisher><subject>Animals ; Cell culture ; Cell Differentiation - physiology ; Cells, Cultured ; Cellular Reprogramming Techniques - methods ; Endothelial cells ; Endothelial Cells - physiology ; Fibroblasts ; Fibroblasts - physiology ; Hindlimb - blood supply ; Hindlimb - physiology ; Human Umbilical Vein Endothelial Cells ; Humans ; Ischemia ; Ischemia - metabolism ; Male ; Mice ; Mice, Nude ; Neovascularization, Physiologic - physiology ; Paracrine signalling ; Phenotypes ; Progenitor cells ; Regenerative medicine ; Skin ; Transcription factors ; Transcription Factors - biosynthesis ; Transcription Factors - genetics</subject><ispartof>Circulation research, 2017-03, Vol.120 (5), p.848-861</ispartof><rights>2016 American Heart Association, Inc.</rights><rights>Copyright Lippincott Williams &amp; Wilkins Ovid Technologies Mar 3, 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c439t-93f2378b7b85c6ec71945aa34919857cedc923a964f804da3b1e5d4e54793f033</citedby><cites>FETCH-LOGICAL-c439t-93f2378b7b85c6ec71945aa34919857cedc923a964f804da3b1e5d4e54793f033</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28003219$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, Sangho</creatorcontrib><creatorcontrib>Park, Changwon</creatorcontrib><creatorcontrib>Han, Ji Woong</creatorcontrib><creatorcontrib>Kim, Ju Young</creatorcontrib><creatorcontrib>Cho, Kyuwon</creatorcontrib><creatorcontrib>Kim, Eun Jae</creatorcontrib><creatorcontrib>Kim, Sangsung</creatorcontrib><creatorcontrib>Lee, Shin-Jeong</creatorcontrib><creatorcontrib>Oh, Se Yeong</creatorcontrib><creatorcontrib>Tanaka, Yoshiaki</creatorcontrib><creatorcontrib>Park, In-Hyun</creatorcontrib><creatorcontrib>An, Hyo Jae</creatorcontrib><creatorcontrib>Shin, Claire Min</creatorcontrib><creatorcontrib>Sharma, Shraya</creatorcontrib><creatorcontrib>Yoon, Young-Sup</creatorcontrib><title>Direct Reprogramming of Human Dermal Fibroblasts Into Endothelial Cells Using ER71/ETV2</title><title>Circulation research</title><addtitle>Circ Res</addtitle><description>Direct conversion or reprogramming of human postnatal cells into endothelial cells (ECs), bypassing stem or progenitor cell status, is crucial for regenerative medicine, cell therapy, and pathophysiological investigation but has remained largely unexplored. We sought to directly reprogram human postnatal dermal fibroblasts to ECs with vasculogenic and endothelial transcription factors and determine their vascularizing and therapeutic potential. We utilized various combinations of 7 EC transcription factors to transduce human postnatal dermal fibroblasts and found that ER71/ETV2 (ETS variant 2) alone best induced endothelial features. KDR (kinase insert domain receptor) cells sorted at day 7 from ER71/ETV2-transduced human postnatal dermal fibroblasts showed less mature but enriched endothelial characteristics and thus were referred to as early reprogrammed ECs (rECs), and did not undergo maturation by further culture. After a period of several weeks' transgene-free culture followed by transient reinduction of ER71/ETV2, early rECs matured during 3 months of culture and showed reduced ETV2 expression, reaching a mature phenotype similar to postnatal human ECs. These were termed late rECs. While early rECs exhibited an immature phenotype, their implantation into ischemic hindlimbs induced enhanced recovery from ischemia. These 2 rECs showed clear capacity for contributing to new vessel formation through direct vascular incorporation in vivo. Paracrine or proangiogenic effects of implanted early rECs played a significant role in repairing hindlimb ischemia. This study for the first time demonstrates that ER71/ETV2 alone can directly reprogram human postnatal cells to functional, mature ECs after an intervening transgene-free period. These rECs could be valuable for cell therapy, personalized disease investigation, and exploration of the reprogramming process.</description><subject>Animals</subject><subject>Cell culture</subject><subject>Cell Differentiation - physiology</subject><subject>Cells, Cultured</subject><subject>Cellular Reprogramming Techniques - methods</subject><subject>Endothelial cells</subject><subject>Endothelial Cells - physiology</subject><subject>Fibroblasts</subject><subject>Fibroblasts - physiology</subject><subject>Hindlimb - blood supply</subject><subject>Hindlimb - physiology</subject><subject>Human Umbilical Vein Endothelial Cells</subject><subject>Humans</subject><subject>Ischemia</subject><subject>Ischemia - metabolism</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Nude</subject><subject>Neovascularization, Physiologic - physiology</subject><subject>Paracrine signalling</subject><subject>Phenotypes</subject><subject>Progenitor cells</subject><subject>Regenerative medicine</subject><subject>Skin</subject><subject>Transcription factors</subject><subject>Transcription Factors - biosynthesis</subject><subject>Transcription Factors - genetics</subject><issn>0009-7330</issn><issn>1524-4571</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpdkUFr3DAQhUVpabZpf0KLoZdenIw0kiVdCovjdBcCgU3SHoXslTcOtrWV7EL_fbVsmiY9DcN87zGPR8hHCmeUFvS8XG_KTXWzXC0P-xmCVoivyIIKxnMuJH1NFgCgc4kIJ-RdjA8AlCPTb8kJUwDIqF6QHxddcM2Ubdw--F2ww9CNu8y32Woe7JhduDDYPrvs6uDr3sYpZutx8lk1bv107_ouHUvX9zG7iwdhtZH0vLr9zt6TN63to_vwOE_J3WV1W67yq-tv63J5lTcc9ZRrbBlKVctaiaZwjaSaC2uRa6qVkI3bNpqh1QVvFfCtxZo6seVOcJmkgHhKvh5993M9JNqNU7C92YdusOG38bYzLy9jd292_pcRiIVgkAy-PBoE_3N2cTJDF5sUyY7Oz9FQJWihJWUqoZ__Qx_8HMYUzzCAQikFUiZKHKkm-BiDa5-eoWAO1Zl_1R12c6wu6T49T_Kk-tsV_gG_0pRF</recordid><startdate>20170303</startdate><enddate>20170303</enddate><creator>Lee, Sangho</creator><creator>Park, Changwon</creator><creator>Han, Ji Woong</creator><creator>Kim, Ju Young</creator><creator>Cho, Kyuwon</creator><creator>Kim, Eun Jae</creator><creator>Kim, Sangsung</creator><creator>Lee, Shin-Jeong</creator><creator>Oh, Se Yeong</creator><creator>Tanaka, Yoshiaki</creator><creator>Park, In-Hyun</creator><creator>An, Hyo Jae</creator><creator>Shin, Claire Min</creator><creator>Sharma, Shraya</creator><creator>Yoon, Young-Sup</creator><general>Lippincott Williams &amp; Wilkins Ovid Technologies</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170303</creationdate><title>Direct Reprogramming of Human Dermal Fibroblasts Into Endothelial Cells Using ER71/ETV2</title><author>Lee, Sangho ; Park, Changwon ; Han, Ji Woong ; Kim, Ju Young ; Cho, Kyuwon ; Kim, Eun Jae ; Kim, Sangsung ; Lee, Shin-Jeong ; Oh, Se Yeong ; Tanaka, Yoshiaki ; Park, In-Hyun ; An, Hyo Jae ; Shin, Claire Min ; Sharma, Shraya ; Yoon, Young-Sup</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c439t-93f2378b7b85c6ec71945aa34919857cedc923a964f804da3b1e5d4e54793f033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Animals</topic><topic>Cell culture</topic><topic>Cell Differentiation - physiology</topic><topic>Cells, Cultured</topic><topic>Cellular Reprogramming Techniques - methods</topic><topic>Endothelial cells</topic><topic>Endothelial Cells - physiology</topic><topic>Fibroblasts</topic><topic>Fibroblasts - physiology</topic><topic>Hindlimb - blood supply</topic><topic>Hindlimb - physiology</topic><topic>Human Umbilical Vein Endothelial Cells</topic><topic>Humans</topic><topic>Ischemia</topic><topic>Ischemia - metabolism</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Nude</topic><topic>Neovascularization, Physiologic - physiology</topic><topic>Paracrine signalling</topic><topic>Phenotypes</topic><topic>Progenitor cells</topic><topic>Regenerative medicine</topic><topic>Skin</topic><topic>Transcription factors</topic><topic>Transcription Factors - biosynthesis</topic><topic>Transcription Factors - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Sangho</creatorcontrib><creatorcontrib>Park, Changwon</creatorcontrib><creatorcontrib>Han, Ji Woong</creatorcontrib><creatorcontrib>Kim, Ju Young</creatorcontrib><creatorcontrib>Cho, Kyuwon</creatorcontrib><creatorcontrib>Kim, Eun Jae</creatorcontrib><creatorcontrib>Kim, Sangsung</creatorcontrib><creatorcontrib>Lee, Shin-Jeong</creatorcontrib><creatorcontrib>Oh, Se Yeong</creatorcontrib><creatorcontrib>Tanaka, Yoshiaki</creatorcontrib><creatorcontrib>Park, In-Hyun</creatorcontrib><creatorcontrib>An, Hyo Jae</creatorcontrib><creatorcontrib>Shin, Claire Min</creatorcontrib><creatorcontrib>Sharma, Shraya</creatorcontrib><creatorcontrib>Yoon, Young-Sup</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Circulation research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Sangho</au><au>Park, Changwon</au><au>Han, Ji Woong</au><au>Kim, Ju Young</au><au>Cho, Kyuwon</au><au>Kim, Eun Jae</au><au>Kim, Sangsung</au><au>Lee, Shin-Jeong</au><au>Oh, Se Yeong</au><au>Tanaka, Yoshiaki</au><au>Park, In-Hyun</au><au>An, Hyo Jae</au><au>Shin, Claire Min</au><au>Sharma, Shraya</au><au>Yoon, Young-Sup</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Direct Reprogramming of Human Dermal Fibroblasts Into Endothelial Cells Using ER71/ETV2</atitle><jtitle>Circulation research</jtitle><addtitle>Circ Res</addtitle><date>2017-03-03</date><risdate>2017</risdate><volume>120</volume><issue>5</issue><spage>848</spage><epage>861</epage><pages>848-861</pages><issn>0009-7330</issn><eissn>1524-4571</eissn><abstract>Direct conversion or reprogramming of human postnatal cells into endothelial cells (ECs), bypassing stem or progenitor cell status, is crucial for regenerative medicine, cell therapy, and pathophysiological investigation but has remained largely unexplored. We sought to directly reprogram human postnatal dermal fibroblasts to ECs with vasculogenic and endothelial transcription factors and determine their vascularizing and therapeutic potential. We utilized various combinations of 7 EC transcription factors to transduce human postnatal dermal fibroblasts and found that ER71/ETV2 (ETS variant 2) alone best induced endothelial features. KDR (kinase insert domain receptor) cells sorted at day 7 from ER71/ETV2-transduced human postnatal dermal fibroblasts showed less mature but enriched endothelial characteristics and thus were referred to as early reprogrammed ECs (rECs), and did not undergo maturation by further culture. After a period of several weeks' transgene-free culture followed by transient reinduction of ER71/ETV2, early rECs matured during 3 months of culture and showed reduced ETV2 expression, reaching a mature phenotype similar to postnatal human ECs. These were termed late rECs. While early rECs exhibited an immature phenotype, their implantation into ischemic hindlimbs induced enhanced recovery from ischemia. These 2 rECs showed clear capacity for contributing to new vessel formation through direct vascular incorporation in vivo. Paracrine or proangiogenic effects of implanted early rECs played a significant role in repairing hindlimb ischemia. This study for the first time demonstrates that ER71/ETV2 alone can directly reprogram human postnatal cells to functional, mature ECs after an intervening transgene-free period. These rECs could be valuable for cell therapy, personalized disease investigation, and exploration of the reprogramming process.</abstract><cop>United States</cop><pub>Lippincott Williams &amp; Wilkins Ovid Technologies</pub><pmid>28003219</pmid><doi>10.1161/CIRCRESAHA.116.309833</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0009-7330
ispartof Circulation research, 2017-03, Vol.120 (5), p.848-861
issn 0009-7330
1524-4571
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5336520
source Freely Accessible Journals
subjects Animals
Cell culture
Cell Differentiation - physiology
Cells, Cultured
Cellular Reprogramming Techniques - methods
Endothelial cells
Endothelial Cells - physiology
Fibroblasts
Fibroblasts - physiology
Hindlimb - blood supply
Hindlimb - physiology
Human Umbilical Vein Endothelial Cells
Humans
Ischemia
Ischemia - metabolism
Male
Mice
Mice, Nude
Neovascularization, Physiologic - physiology
Paracrine signalling
Phenotypes
Progenitor cells
Regenerative medicine
Skin
Transcription factors
Transcription Factors - biosynthesis
Transcription Factors - genetics
title Direct Reprogramming of Human Dermal Fibroblasts Into Endothelial Cells Using ER71/ETV2
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T07%3A49%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Direct%20Reprogramming%20of%20Human%20Dermal%20Fibroblasts%20Into%20Endothelial%20Cells%20Using%20ER71/ETV2&rft.jtitle=Circulation%20research&rft.au=Lee,%20Sangho&rft.date=2017-03-03&rft.volume=120&rft.issue=5&rft.spage=848&rft.epage=861&rft.pages=848-861&rft.issn=0009-7330&rft.eissn=1524-4571&rft_id=info:doi/10.1161/CIRCRESAHA.116.309833&rft_dat=%3Cproquest_pubme%3E2006888077%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c439t-93f2378b7b85c6ec71945aa34919857cedc923a964f804da3b1e5d4e54793f033%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2006888077&rft_id=info:pmid/28003219&rfr_iscdi=true